I'll keep adding to my 5000 shares that I bought at an average cost of $2.75, I'm already up hoping to adding an additional 5000 by the end of the year.
Just keep paying the interest on that short position, your in whole that you can't get out of.
All I can say is continue paying interest on those shares boys. Retail holding at 50% for the last 3 years easy.
Let's see who owns Stanford and Ashburn fake online news outlets!
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has a short ratio of 2.49. Higher the ratio, the more pressurized the stock will be, lower the ratio, lesser the duress on the stock. The short interest has seen a change of -3.06% in the past month. The 3-month change in short interest was measured at -12.21%. The ratio of monthly shorts to total outstanding shares stands at 0.154. The average daily volume for the last 20 days is 17,000,396 shares. The 20-day volume is 6.96% of the total shares outstanding. A low short ratio indicates marginal bearishness while a high short ratio represents excessive pessimism. Bulls led the way in the counter of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) which ended 3.7% or 0.16 points higher. During the day, every dip till $4.34 was used to accumulate the stock which last traded at $4.48. The close is near the highest level of the day, i.e. $4.49 and this is a sign of strong upward momentum. The volume was seen at 4,356,339 shares. The counter had ended the previous session at $4.32. The 52-week high of the shares is $7.36 and the 52-week low is $3.26. The company has 244,322,000 outstanding shares and the market cap stands at $1,095 million
7Million Shares. Let me guess they where buying them to short them. COME ON MAN!!!!!!!!!!
Accept your demise. you shorted @ $4 and now you're stuck!!!! That's why you're here every single day trying to nickel and dime your way back to the up side.
How said. They still can get the longs 50% ownership in this company. TOO FUNNY!!!!!!
It amazes me that you're even still here. Go look at the NASDAQ website buddy. I believe institutions have accumulated an additional 4 Million shares from Septembers reporting period and the short interest has decreased approximately the same amount.
You and you short buddies have been on this board daily trying to get longs to sell. You should be on the TV show; what do they call it, YEAH THE BIGGEST LOSER!
JC has found himself another Chogey Boy! Faber you have to business selling business info, dude you have degree in communications!!!! No certifications (not series 7 or 66 put you're giving advice please!)
How does the SEC allow folks on CNBC with absolutely NO CERTIFICATIONS GIVE ANY ADVICE!!!!! Just sick.
In 2010, retail investors started accumulating shares at $2-$3, price goes up to $13.50 some us sold and made a nice profit. At that time retail owned 75% and institutions owned 25%. Now institutions/market makers have Manipulated the price down to three-ish, back up to $6, and down to $4 ish. All the while letting their buddies save face by covering their short positions to save face. Let's face it they own the market so they can set any price they want. So I hate to say it but I too want retail longs to sell their shares. The sooner they do the sooner institutions can buy their short positions then start to artificially inflate the price.
If you don't believe me look at all the $70-100+ Biotechs. The institutions own 70% or more of the companies outstanding shares. So longs hurry up and sell all your shares.
All this really means is who's an investor vs. Who's a trader. Investors are in for the long hall. You look at all the biotechs it's taken years to get off the ground. CELG, BIIB, GILD, they didn't just wake up one day and their stock price was at 80+ per share it took 10+ years. So, if your long good for ya, if your short, stay off the board unless you have some note worthy information to pass. If you're trader keep hoping and wishing for that golden ticket, it's not coming here overnight.
They will bash about, the revenue, the leadership, etc.. But answer this Shorty. Why are institutions buying, short interest decreasing in millions, and you here bashing 24/7, if this company didn't have potential?
Well, seeing that the average retail investor doesn't have time to monitor his investment every 10 minutes, We read the studies, occassionally look at the finances, and read the latest news. Again, Rome wasn't built in a day. (CELG, BIIB, LLY, GILD, etc. all had promising pipelines). As for Dendreon if you where a smart investor. You should've known the dynamics behind it's failure.
ARNA has 220M Outstanding Shares; 38M Short; 5.7% Short Interest; What do you think will happen here. When the real news starts coming out. Here's my prediction IMHO. If new stating ARNA is accepted in Korea, Brazil, or any other country a $1 pop. News Belviq is accepted for Smoking Cessation $3 pop, Studies from additional pipleine encouraging $2 pop. Short Interest rebuying magnify that by 3 to 5 times. $30 to $55 pps.
By the way DNDN had almost the exact same Short Interest and Shares outstanding. Stock price shot up to $55 over the course of a year.
Like JC said you said the exact opposite of what you do when trying to drive the price down. You say the stock is worthless provide you buddies with false and misleading information, all the while you are purchasing hand over fist.... You want proof-look at the short interest since Jan 14. from 68 Million down to 38 Million; Institutional ownership from 25% to 49%. MM, short interest and Institutions usually all one in the same depress the price to retail longs will pop smoke. All the while they begin accumulating shares. Again, not heresay but the proof is in the numbers. They HF, Short Interest and Institutions will continue to hammer as long as they can until they can accumulate 70% of the shares. Then march the price to where they think it should be. It has nothing to do with the fundamentals; you can look at several biotechs in the $70-$130 pps range and they are not profitable have not FCF, and their EPS is much lower than ARNA. But is you look at their institutional ownership is usually in the 90% range. "Ironic I think NOT"
Do the math....
How did roughly 80 Million shares get bought?
Because you can't buy what you don't own, Only thing you can do is print fake shares. "Ala Naked shorting". Retail owns 49%, Instititutions own 49%, You short mongrels are trading short between each other. Continue to do so but someone will blink, and I assure you it will not be the retail longs who have been long since two dollars!!!
Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) [Detail Analytic Report] declared that it has submitted a Clinical Trial Application with the United Kingdom’s Medicines Healthcare products Regulatory Agency looking for regulatory authorization to start clinical trials for the sustained development of its lead molecule, Anatabine Citrate. Depending on the Firm receiving CTA regulatory authorization, the Firm intends to conduct a Phase I trial to evaluate the safety, tolerability and dose growth of Anatabine Citrate with Quotient Clinical, a UK located contract research organization (CRO). Quotient Clinical will employ its (Rapid Formulation development And Clinical Testing) service to test innovative, oral, improved release Anatabine Citrate formulations which have been developed mutually with the firm.